Compositions comprising biotransformed fruit extracts and methods of using the compositions in the prevention and treatment of cancer are provided. The fruit extracts are biotransformed by fermentation with a bacterial strain having all the identifying characteristics of Serratia vaccinii. The compositions can be used to inhibit tumour growth, tumour metastasis and cancer stem cell (CSC) development.
